Cleared Traditional

K896690 - MODIFIED ANGIOGRAPHIC CATHETER

K896690 is the FDA 510(k) clearance for MODIFIED ANGIOGRAPHIC CATHETER by Novoste Corp.. It is a Class 2 Cardiovascular device (product code DQO) cleared through the Traditional 510(k) pathway after a 57-day FDA review.

K896690 · Novoste Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
57d
Days
Class 2
Risk

K896690 is an FDA 510(k) clearance for the MODIFIED ANGIOGRAPHIC CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Novoste Corp. (Aguadilla, US). The FDA issued a Cleared decision on January 24, 1990 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Novoste Corp. devices

Submission Details

510(k) Number K896690 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 28, 1989
Decision Date January 24, 1990
Days to Decision 57 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 125d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 292
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K896690.
USCI 7F LARGE LUMEN GUIDING CATHETER
K895180 · C.R. Bard, Inc. · Apr 1990
SONICATH(TM) 5 F
K895542 · Boston Scientific Corp · Apr 1990
CORDIS SHUTTLE CATHETER
K896308 · Cordis Corp. · Mar 1990
MULTILUMEN CENTRAL VENOUS CATHETER
K885221 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1989
SWAN-GANZ THERM CATH SM HEART AMC THROM 93A102H5F
K894168 · Baxter Healthcare Corp · Nov 1989
ARROW HANDS-OFF THERMO-PACE
K895268 · Arrow Intl., Inc. · Nov 1989